This section includes information and resources about Stroke Prevention in Atrial Fibrillation (AF) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos. For additional information please visit Newshome.
Extensive experience in clinical practice and expanding research programme support use of Pradaxa® for clot prevention
New Pradaxa® data to be presented at the ESC Congress 2014
First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting
U.S. FDA grants Breakthrough Therapy Designation to Pradaxa® (dabigatran etexilate) specific investigational antidote- For media outside of the U.S., the UK & Canada only
New Pradaxa® clinical study to explore practical management of patients with atrial fibrillation undergoing ablation- For media outside of the U.S., the UK & Canada only
The Education Hub on Newshome offers the latest information regarding